Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Metabotropic Glutamate Receptor 5 ELISA Kit (AC2711)
Cat.#: ASET-1300
Specifications
Description Mouse Metabotropic Glutamate Receptor 5 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse Metabotropic Glutamate Receptor 5 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.62 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 150-2400 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2281 Human Neurotensin ELISA Kit (AC3692) Quantitative inquiry ASET-1883 Human 5HT1B Receptor ELISA Kit (AC3294) Quantitative inquiry ASET-1073 Human FGFR4 ELISA Kit (AC2484) Quantitative inquiry ASET-2028 Mouse Has2 ELISA Kit (AC3439) Quantitative inquiry ASET-2346 Human AGRP ELISA Kit (AC3757) Quantitative inquiry ASET-1092 Guinea Pig PEDF ELISA Kit (AC2503) Quantitative inquiry ASET-1987 Mouse DCAMKL1 ELISA Kit (AC3398) Quantitative inquiry ASET-1311 Rat alpha Synuclein ELISA Kit (AC2722) Quantitative inquiry ASET-2192 Human CRHR2 ELISA Kit (AC3603) Quantitative inquiry ASET-1285 Human Serotonin Transporter ELISA Kit (AC2696) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket